Medical Condition News

RSS

Two-drug combination may alleviate radiation sickness in people

A combination of two drugs may alleviate radiation sickness in people who have been exposed to high levels of radiation, even when the therapy is given a day after the exposure occurred, according to a study led by scientists from Dana-Farber Cancer Institute and Children's Hospital Boston.

24 Nov 2011

Stress chemicals shut down and brain processes emotional experiences during REM sleep

They say time heals all wounds, and new research from the University of California, Berkeley, indicates that time spent in dream sleep can help. UC Berkeley researchers have found that during the dream phase of sleep, also known as REM sleep, our stress chemistry shuts down and the brain processes emotional experiences and takes the painful edge off difficult memories.

24 Nov 2011

Metformin prevents growth of breast cancer cells in human cultures

An inexpensive drug that treats Type-2 diabetes has been shown to prevent a number of natural and man-made chemicals from stimulating the growth of breast cancer cells, according to a newly published study by a Michigan State University researcher.

24 Nov 2011

Cell-penetrating or antimicrobial peptides could treat atopic eczema

Scientists have found that a strain of yeast implicated in inflammatory skin conditions, including eczema, can be killed by certain peptides and could potentially provide a new treatment for these debilitating skin conditions.

24 Nov 2011

NIH grant to support Cedars-Sinai's Department of Neurology research

The National Institutes of Health has awarded a four-year, $1.4 million grant to Cedars-Sinai's Department of Neurology to study an unexpected recent discovery: After ischemic stroke - the type caused by a clogged artery but with no bleeding into the brain - a normal protein that plays a positive role in blood clotting escapes intact arteries and damages healthy brain cells.

24 Nov 2011

Norway after terrorist attacks on July 22

How will the terrorist attacks in Norway on 22 July change the country? That question has been put to three social scientists at the University of Stavanger.

24 Nov 2011

New First Choice infographic explores issue of SAD and winter blues

First Choice, one of the UK's leading leisure travel companies, has released an infographic that sheds light on how the lack of sunshine during the winter months is affecting a large proportion of the population in northern countries.

24 Nov 2011

Advaxis completes ADXS-HER2 pre-IND meeting with FDA

Advaxis, Inc., a leader in developing the next generation of immunotherapies for cancer and infectious diseases, completed a pre-IND meeting with the FDA on November 22, 2011 to discuss the development plan for ADXS-HER2, an immunotherapy for the treatment of HER2 expressing cancers.

23 Nov 2011

Physical exercise seems to encourage healthy diet

A healthy diet and the right amount of exercise are key players in treating and preventing obesity but we still know little about the relationship both factors have with each other. A new study now reveals that an increase in physical activity is linked to an improvement in diet quality.

23 Nov 2011

Neuralstem initiates spinal cord neural stem cell trial in ALS

Neuralstem, Inc. announced that the first patient to receive stem cells in the cervical (upper back) region of the spine was treated on Friday in its ongoing trial to test the safety of its spinal cord neural stem cells in amyotrophic lateral sclerosis.

23 Nov 2011

Transcept receives FDA approval for Intermezzo to treat insomnia

The U.S. Food and Drug Administration today approved Intermezzo (zolpidem tartrate sublingual tablets) for use as needed to treat insomnia characterized by middle-of-the-night waking followed by difficulty returning to sleep.

23 Nov 2011

JIB highlights aluminium's potential role in neurodegenerative diseases

Aluminium's potential role in neurodegenerative diseases such as Alzheimer's disease and cancer, specifically breast cancer, and the potential role for aluminium adjuvants in vaccine-related adverse effects are spotlighted in the latest issue of the Journal of Inorganic Biochemistry (JIB).

23 Nov 2011

Relationship between anorexia nervosa and authentic self a significant issue

People with anorexia nervosa struggle with questions about their real, or "authentic," self - whether their illness is separate from or integral to them - and this conflict has implications for compulsory treatment, concludes a study in the Hastings Center Report.

23 Nov 2011

Imaging is about finding the most appropriate way to assess heart disease

"The idea is that we're using the most appropriate technology to address individual clinical questions rather than just focusing on one technique," explains EAE President Dr Luigi Badano, from the University of Padua, Italy.

23 Nov 2011

Asymmetric prototypes for mitral valve replacement

The heart's valves, which guarantee the unidirectional flow of blood from one chamber to another, are asymmetrical. For example, the two flaps of the heart's mitral valve - which regulates blood flow between the left atrium and the left ventricle - vary in size by up to 70 percent.

23 Nov 2011

Cancer medicine component could prevent heart attacks

A substance in medicines for cancer and epilepsy could also prevent heart attacks, according to researchers at the Sahlgrenska Academy at the University of Gothenburg, Sweden, who have been using it to stimulate the body's own defence system against blood clots.

23 Nov 2011

BIOTRONIK announces first implantations of new Lumax 740 ICDs

BIOTRONIK, a leading manufacturer of innovative medical technology, announced today the first implantations of the new Lumax 740 implantable cardiac defibrillators—the world's first and only ICDs eligible for use with magnetic resonance imaging.

23 Nov 2011

TLRs contribute to brain damage following hypoxia in newborns

Two out of every thousand babies are at risk of brain damage in connection with birth. Researchers at the Sahlgrenska Academy at the University of Gothenburg, Sweden, have identified mechanisms behind these injuries, which could lead to better treatment and a richer life for the infants affected.

23 Nov 2011

AMP opposes NIH proposal to license cancer-related proteonomics patent

The Association for Molecular Pathology (AMP) opposed the National Institutes of Health (NIH) proposal to exclusively license the subject matter of a cancer-related proteonomics patent application filed by the Agency.

23 Nov 2011